NCT02924844

Brief Summary

The aim of this before-after study was to assess the impact of a clinical pharmacy bundle of care activities on patient outcomes (length of hospital stay as a primary endpoint) and cost expenditure in two French ICUs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,787

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

October 4, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 5, 2016

Completed
Last Updated

June 18, 2026

Status Verified

October 1, 2016

Enrollment Period

2.4 years

First QC Date

October 4, 2016

Last Update Submit

June 17, 2026

Conditions

Intensive Care

Outcome Measures

Primary Outcomes (1)

  • Length of hospital stay

    expected average of 20 days

Secondary Outcomes (5)

  • Intensive Care Unit length of stay

    Expected maximum of 10 days

  • Mechanical ventilation duration

    Expected maximum of 10 days

  • Intensive care unit mortality rate

    Expected maximum of 10 days

  • Hospital mortality rate

    End of hospital stay (expected average of 20 days)

  • Patient cost expenditure

    End of hospital stay (expected average of 20 days)

Other Outcomes (1)

  • The rate of isolation of multidrug resistant organisms

    End of hospital stay (expected average of 20 days)

Study Arms (2)

Observation period before presence of clinical pharmacist

The group of patients was observed between Janary 2013 and December 2013

Period with presence of clinical pharmacist

The group of patients was observed between January 2014 and June 2015.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The two study populations are composed of all patients present in the ICU on weekdays. The first population is composed of patients present between January 2013 and December 2013. The second population is composed of patients present between January 2014 and June 2015.

You may qualify if:

  • Intensive Care Unit patients on weekdays

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nîmes

Nîmes, Gard, 30029, France

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2016

First Posted

October 5, 2016

Study Start

January 1, 2013

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

June 18, 2026

Record last verified: 2016-10

Locations

FR(1)